Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measurement of free (unbound) remimazolam concentration during cardiovascular surgery
jRCT1011230004Recruiting
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam in cardiac morbidity. Primary endpoint: Concentration of free remimazolam. Started Apr 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT1011230004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011230004.